Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI

Clinical trial NCT04232657 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04232657
Sponsor: VA Office of Research and Development
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Spinal Cord Injury (=3 Years)Sublesional Bone Loss Secondary to SCI

Start date: 2021-03-01
Primary completion: 2026-08-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.